• Explore /
  • Poster
  • / Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma.

Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma.

Abstract Poster

Authors

Ghassan Abou-Alfa

Ghassan K. Abou-Alfa

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Cornell University, New York, NY

Ghassan K. Abou-Alfa , Wei-Peng Yong , Stephen Lam Chang , Jia Fan , Han Chong Toh , Thomas Yau , SuPin Choo , Jing Wang , Nicole Kusuma , Christy Ma , Shukui Qin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT05417932

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS4181)

DOI

10.1200/JCO.2023.41.16_suppl.TPS4181

Abstract #

TPS4181

Poster Bd #

497a

Abstract Disclosures

Similar Posters

First Author: Ann-Lii Cheng

First Author: Peter R. Galle

First Author: Yu Yun Shao

First Author: T.R. Jeffry Evans